Last reviewed · How we verify
NCT04892238
Helicobacter Pylori Infection Occurrence in Russia
trial testing 13-C urea breath test in Helicobacter Pylori Infection in 70,000 participants. Completed in 31 July 2020.
31 December 2019
Quick facts
| Lead sponsor | Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70,000 |
| Start date | 1 January 2017 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 July 2020 |
| Sites | 2 locations across Russia |
Drugs / interventions tested
- 13-C urea breath test
Conditions studied
- Helicobacter Pylori Infection — all drugs for Helicobacter Pylori Infection →
Sponsor
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Who can join
12 and older, any sex, with Helicobacter Pylori Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is planned to reveal the occurrence rate of H.pylori infection in ambulatory settings' patients in Russia and to compare the occurrence rates in different years in treatment-naïve and previously treated subjects.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Helicobacter pylori infection prevalence in ambulatory settings in 2017-2019 in RUSSIA: The data of real-world national multicenter trial.
Bordin D, Morozov S, Plavnik R, Bakulina N, et al · · 2022 · cited 8× · PMID 35971900 · DOI 10.1111/hel.12924
Verify or expand the search:
- PubMed search for NCT04892238
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Helicobacter Pylori Infection
Currently open trials in the same condition.
- NCT07285096 — P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication · recruiting
- NCT07358130 — Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy · NA · recruiting
- NCT07165444 — Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatme · NA · recruiting
- NCT06929962 — VA Dual Sequential Therapy · Phase 4 · recruiting
- NCT06959368 — Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication · Phase 4 · recruiting
Other Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology trials
Trials by the same sponsor.
- NCT06727279 — Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profi · NA · not yet recruiting
- NCT07121803 — The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility · NA · recruiting
- NCT06724913 — Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice C · NA · active not recruiting
- NCT05543811 — The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyri · NA · completed
- NCT05224037 — Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04892238 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
- Last refreshed: 19 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04892238.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing